Sellas Historical Cash Flow
SLS Stock | USD 1.17 0.05 4.10% |
Analysis of Sellas Life cash flow over time is an excellent tool to project Sellas Life Sciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Total Cash From Financing Activities of 25.2 M or End Period Cash Flow of 2.5 M as it is a great indicator of Sellas Life ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Sellas Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Sellas Life Sciences is a good buy for the upcoming year.
Sellas |
About Sellas Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Sellas balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Sellas's non-liquid assets can be easily converted into cash.
Sellas Life Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Sellas Life's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Sellas Life Sciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sellas Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At this time, Sellas Life's Change To Netincome is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 1.1 M in 2024, whereas Free Cash Flow is likely to drop (38.8 M) in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Begin Period Cash Flow | 35.4M | 21.5M | 17.2M | 17.8M | End Period Cash Flow | 21.5M | 17.2M | 2.6M | 2.5M |
Sellas Life cash flow statement Correlations
Click cells to compare fundamentals
Sellas Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sellas Life cash flow statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | 1.9M | 28.0M | (13.9M) | (4.2M) | (14.6M) | (13.9M) | |
Free Cash Flow | (17.6M) | (10.4M) | (26.0M) | (28.3M) | (36.9M) | (38.8M) | |
Change In Working Capital | (1.1M) | 5.6M | (7.6M) | 5.6M | 3.3M | 3.5M | |
Other Cashflows From Financing Activities | 19.6M | 8.8M | 3.1M | 85K | 90K | 85.5K | |
Other Non Cash Items | 586K | (87K) | (4.2M) | 10.1M | 1.2M | 621.0K | |
Total Cash From Operating Activities | (17.6M) | (10.4M) | (26.0M) | (23.8M) | (31.4M) | (33.0M) | |
Net Income | (19.3M) | (16.8M) | (20.7M) | (41.3M) | (37.3M) | (39.2M) | |
Total Cash From Financing Activities | 19.6M | 38.4M | 12.1M | 24.1M | 22.3M | 25.2M | |
End Period Cash Flow | 7.4M | 35.4M | 21.5M | 17.2M | 2.6M | 2.5M | |
Begin Period Cash Flow | 5.5M | 7.4M | 35.4M | 21.5M | 17.2M | 17.8M | |
Depreciation | 1.7M | 282K | 5.7M | 457K | 525.6K | 992.1K | |
Stock Based Compensation | 573K | 578K | 1.0M | 1.7M | 1.4M | 1.8M | |
Sale Purchase Of Stock | 31.2M | 19.6M | 38.1M | (31K) | (27.9K) | (26.5K) | |
Cash And Cash Equivalents Changes | (3.6M) | (7.3M) | 1.9M | 28.0M | 32.2M | 33.8M | |
Cash Flows Other Operating | 331K | (27.8M) | (19.9M) | (10.9M) | (9.8M) | (10.3M) | |
Change To Netincome | 3.3M | 750K | 2.3M | 11.9M | 13.6M | 14.3M | |
Change To Liabilities | (1.0M) | 4.8M | (8.1M) | 1.2M | 1.1M | 1.1M | |
Change To Operating Activities | (1.1M) | 826K | 498K | 4.4M | 5.1M | 5.3M | |
Issuance Of Capital Stock | 16.0M | 29.6M | 9.0M | 24.0M | 19.8M | 17.3M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sellas Stock Analysis
When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.